Wednesday, 19 November 2025
  
Login

Australia's most trusted
source of pharma news

Wednesday, 19 November 2025
News

CSL joins US manufacturing rush

Posted 19 November 2025 PM

CSL will spend about US$1.5 billion on expanding its US manufacturing facilities, joining a long line of pharma companies expanding their US footprint in the wake of Donald Trump’s tariff threats.

The investment over the next five years will create hundreds of jobs, strengthen US manufacturing capabilities for plasma-derived therapies, and help secure the US medicine supply chain, reflecting the company’s commitment to meet the growing clinical need for immunoglobulin over the long term, CSL said.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (15)

Clinical & Medical, R&D (5)

Regulatory, Pharmacovigilance & QA (5)

Other (13)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.